GlassScriptPhysician profile
Loan Tp Haase
NPI 1659682490
$1,115.06
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $164 · 2021: $388 · 2022: $27.10 · 2023: $89.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.16 | 2021-2022 | |
| Amgen INC. | $145.86 | 2019-2021 | |
| Pfizer INC. | $104.24 | 2019-2021 | |
| Allergan, INC. | $102.34 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.36 | 2019 | |
| Intuitive Surgical, INC. | $89.69 | 2023 | Da Vinci Surgical System |
| Janssen Pharmaceuticals, INC | $54.06 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.57 | 2019-2021 | |
| Novo Nordisk INC | $44.75 | 2019-2021 | |
| Glaxosmithkline, LLC. | $38.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.47 | 2019 | |
| Astellas Pharma US INC | $30.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $28.26 | 2020-2021 | |
| Sanofi Pasteur INC. | $26.66 | 2019-2020 | |
| Amarin Pharma, INC. | $26.21 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $20.64 | 2019 | |
| Lilly USA, LLC | $13.90 | 2021 | |
| Boston Scientific Corporation | $12.58 | 2019 | |
| Strongbridge US INC. | $11.93 | 2019 | |
| Abbott Laboratories | $11.86 | 2019 | |
| Fidia Pharma USA INC. | $5.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loan Haase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.